These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23052639)

  • 1. Dronedarone reduces arterial thrombus formation.
    Breitenstein A; Sluka SH; Akhmedov A; Stivala S; Steffel J; Camici GG; Riem HH; Beer HJ; Studt JD; Duru F; Luscher TF; Tanner FC
    Basic Res Cardiol; 2012 Nov; 107(6):302. PubMed ID: 23052639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone inhibits arterial thrombus formation and tissue factor translation.
    Breitenstein A; Stämpfli SF; Camici GG; Akhmedov A; Ha HR; Follath F; Bogdanova A; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2231-8. PubMed ID: 18974383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation.
    Holy EW; Besler C; Reiner MF; Camici GG; Manz J; Beer JH; Lüscher TF; Landmesser U; Tanner FC
    Thromb Haemost; 2014 Nov; 112(5):1024-35. PubMed ID: 25056722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation.
    Holy EW; Forestier M; Richter EK; Akhmedov A; Leiber F; Camici GG; Mocharla P; Lüscher TF; Beer JH; Tanner FC
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1772-80. PubMed ID: 21571683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions.
    Zafar MU; Santos-Gallego CG; Smith DA; Halperin JL; Badimon JJ
    Atherosclerosis; 2017 Nov; 266():81-86. PubMed ID: 28992468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.
    Agelaki MG; Pantos C; Korantzopoulos P; Tsalikakis DG; Baltogiannis GG; Fotopoulos A; Kolettis TM
    Eur J Pharmacol; 2007 Jun; 564(1-3):150-7. PubMed ID: 17391666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
    Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
    Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restraint stress enhances arterial thrombosis in vivo--role of the sympathetic nervous system.
    Stämpfli SF; Camici GG; Keller S; Rozenberg I; Arras M; Schuler B; Gassmann M; Garcia I; Lüscher TF; Tanner FC
    Stress; 2014 Jan; 17(1):126-32. PubMed ID: 24215418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone and Captisol-enabled amiodarone in an experimental cardiac arrest.
    Glover BM; Hu X; Aves T; Ramadeen A; Zou L; Leong-Poi H; Fujii H; Dorian P
    J Cardiovasc Pharmacol; 2013 May; 61(5):385-90. PubMed ID: 23542680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
    Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
    Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
    Jiang P; Xue D; Zhang Y; Ye L; Liu Y; Makale M; Kesari S; Edgington TS; Liu C
    Thromb Res; 2014 Apr; 133(4):657-66. PubMed ID: 24485401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
    Chevalier P; Timour Q; Morel E; Bui-Xuan B
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):523-8. PubMed ID: 22330675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.